NRIM Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
63.9M
+6.9%
59.8M
-4.1%
62.3M
-19.3%
77.2M
+25.7%
61.4M
Cost of Revenue
10.0M
-2.1%
10.2M
-4.0%
10.7M
+0.3%
10.6M
-5.1%
11.2M
Gross Profit
53.9M
+8.7%
49.5M
-4.1%
51.7M
-22.4%
66.6M
+32.6%
50.2M
Operating Expenses
32.0M
+4.6%
30.6M
-8.4%
33.4M
+10.3%
30.3M
-6.7%
32.5M
R&D
SG&A
7.4M
-0.6%
7.5M
-8.6%
8.2M
+20.5%
6.8M
-11.1%
7.6M
Operating Income
20.2M
+12.6%
18.0M
+8.1%
16.6M
-52.0%
34.6M
+119.2%
15.8M
EBITDA
20.2M
+12.6%
18.0M
+8.1%
16.6M
-52.0%
34.6M
+119.2%
15.8M
Net Income
15.3M
+12.2%
13.7M
+9.9%
12.4M
-54.0%
27.1M
+129.8%
11.8M
EPS (Basic)
$0.69
+11.3%
$0.62
+10.7%
$0.56
-54.5%
$1.23
+132.1%
$0.53
EPS (Diluted)
$0.68
+11.5%
$0.61
+10.9%
$0.55
-54.2%
$1.20
+130.8%
$0.52
Shares (Diluted)
22.5M
-0.1%
22.6M
+0.1%
22.6M
+0.3%
22.5M
+0.3%
22.4M
Northrim Ban (NRIM) — Financials